SpringWorks Therapeutics Inc (SWTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

100 WASHINGTON BOULEVARD STAMFORD, CT 06902

SpringWorks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company acquires, develops, and commercializes medicines for patients suffering various diseases and cancer. SpringWorks Therapeutics serves customers in the United States.

Data based on most recent fiscal year report
Market Cap1.528 Billion Shares Outstanding43.01 Million Avg Volume99.26 Thousand

Are you looking for this stock instead?

View SEC Filings from SWTX instead.

View recent insider trading info

Funds Holding SWTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SWTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SQUINTO STEPHEN P

  • Director
  • 10% Owner
0 2020-03-12 1

ISLAM SAQIB

  • Director
5,000 2020-03-03 1

SMITH L. MARY SEE REMARKS

  • Officer
0 2020-03-02 1

FRANCIS PERIER I JR CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-02 1

RENSTRUP JENS CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-02 1

EDRIS BADREDDIN CHIEF BUSINESS OFFICER

  • Officer
0 2020-03-02 1

WEINSTEIN HERSCHEL S GENERAL COUNSEL AND SECRETARY

  • Officer
0 2020-02-03 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SQUINTO STEPHEN P - Director - > 10% Owner

2020-03-12 A 20,000 a 20,000 0.00 direct

ISLAM SAQIB - Director - Officer CHIEF EXECUTIVE OFFICER

2020-03-02 A 325,000 a 325,000 0.00 direct

FRANCIS PERIER I JR - Officer CHIEF FINANCIAL OFFICER

2020-03-02 A 75,000 a 75,000 0.00 direct

EDRIS BADREDDIN - Officer CHIEF BUSINESS OFFICER

2020-03-02 A 100,000 a 100,000 0.00 direct

SMITH L. MARY - Officer SEE REMARKS

2020-03-02 A 75,000 a 75,000 0.00 direct

RENSTRUP JENS - Officer CHIEF MEDICAL OFFICER

2020-03-02 A 50,000 a 50,000 0.00 direct

Elevate your investments